New Whitepaper: Origination in the Age of AI–How signal-driven infrastructure is replacing broker-dependent deal flow.Read now↗

PE Firms M&A Firms Commercial Lenders Investment Banks
Deal Origination
End-to-end outreach infrastructure that sources proprietary deal flow.
Data & Research
TAM mapping, data enrichment, custom scraping, and automated research.
Trigger Intelligence (Signals)
Signal-driven deal intelligence delivered to your CRM, Slack, and email.
Resources
Playbooks
Channel-specific outreach playbooks for deal origination.
All research
Comparison posts, methodology, and analysis from the Tentt team.
Reports
Monthly market reports on M&A and private equity activity.
Tools
Free calculators for M&A, lending, and deal analysis.
Whitepaper↗
Origination in the Age of AI.
About
Book an intro call

Sun Pharma — Acquisitions & M&A Deals

6 deals

Tracking 6 M&A deals by Sun Pharma.

Sun Pharma puts seal on $11.75B Organon buyout - FirstWord Pharma

HealthcareMerger

Sun Pharma→Organon

Apr 27, 2026

Sun Pharma shares jump 5% after $11.75 billion Organon acquisition deal - Fortune India

HealthcareMerger

Sun Pharma→Organon

Apr 27, 2026

Sun Pharma share price rises 5% on acquisition of US-based Organon. What should investors do? - Mint

HealthcareMerger

Sun Pharma→Organon

Apr 27, 2026

Sun Pharma Signs $11.75B Definitive Agreement to Acquire Organon & Co. - scanx.trade

HealthcarePlatform

Sun Pharma→Organon

Apr 26, 2026

Sun Pharma signs Definitive Agreement to Acquire Organon - The Joplin Globe

HealthcareMerger

Sun Pharma→Organon

Apr 26, 2026

Sun Pharma signs Definitive Agreement to Acquire Organon - Business Wire

HealthcareMerger

Sun Pharma→Organon

Apr 26, 2026